PL360972A1 - Nowa kompozycja farmaceutyczna w postaci kapsułekcelulozowych odpowiednich dla pochodnych benzimidazolu - Google Patents

Nowa kompozycja farmaceutyczna w postaci kapsułekcelulozowych odpowiednich dla pochodnych benzimidazolu

Info

Publication number
PL360972A1
PL360972A1 PL36097201A PL36097201A PL360972A1 PL 360972 A1 PL360972 A1 PL 360972A1 PL 36097201 A PL36097201 A PL 36097201A PL 36097201 A PL36097201 A PL 36097201A PL 360972 A1 PL360972 A1 PL 360972A1
Authority
PL
Poland
Prior art keywords
capsule
derivatives
omeprazole
cellulose
containing benzimidazole
Prior art date
Application number
PL36097201A
Other languages
English (en)
Inventor
Judita Sirca
Original Assignee
Lek Farmacevtska Druzba D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL360972(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Farmacevtska Druzba D.D. filed Critical Lek Farmacevtska Druzba D.D.
Publication of PL360972A1 publication Critical patent/PL360972A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL36097201A 2000-11-20 2001-11-20 Nowa kompozycja farmaceutyczna w postaci kapsułekcelulozowych odpowiednich dla pochodnych benzimidazolu PL360972A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200000282A SI20720A (sl) 2000-11-20 2000-11-20 Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
PCT/SI2001/000031 WO2002039980A2 (en) 2000-11-20 2001-11-20 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole

Publications (1)

Publication Number Publication Date
PL360972A1 true PL360972A1 (pl) 2004-09-20

Family

ID=20432767

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36097201A PL360972A1 (pl) 2000-11-20 2001-11-20 Nowa kompozycja farmaceutyczna w postaci kapsułekcelulozowych odpowiednich dla pochodnych benzimidazolu

Country Status (9)

Country Link
US (2) US20040029924A1 (pl)
EP (1) EP1335709B1 (pl)
AT (1) ATE324873T1 (pl)
AU (2) AU1452402A (pl)
DE (1) DE60119367T2 (pl)
ES (1) ES2263675T3 (pl)
PL (1) PL360972A1 (pl)
SI (1) SI20720A (pl)
WO (1) WO2002039980A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CA2540105A1 (en) * 2003-09-25 2005-03-31 Natco Pharma Limited Enteric soft gelatin capsule containing esomeprazole and method of preparation
WO2005034924A1 (en) * 2003-10-14 2005-04-21 Natco Pharma Limited Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
EP1721604A4 (en) * 2004-03-04 2008-04-30 Takeda Pharmaceutical STABLE CAPSULE PREPARATION
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2008018825A1 (en) * 2006-08-10 2008-02-14 Astrazeneca Ab Oral polyvinyl alcohol capsules comprising proton pump inhibitors
CN116251075B (zh) * 2023-03-31 2024-11-29 江苏慧聚药业股份有限公司 一种兰索拉唑肠溶胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5431917A (en) * 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
US20040029924A1 (en) 2004-02-12
US20090226511A1 (en) 2009-09-10
ES2263675T3 (es) 2006-12-16
AU2002214524B2 (en) 2007-03-01
ATE324873T1 (de) 2006-06-15
WO2002039980A2 (en) 2002-05-23
AU1452402A (en) 2002-05-27
SI20720A (sl) 2002-06-30
DE60119367T2 (de) 2007-04-19
EP1335709B1 (en) 2006-05-03
EP1335709A2 (en) 2003-08-20
DE60119367D1 (de) 2006-06-08
WO2002039980A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
ZA200205512B (en) Novel substituted benzimidazole dosage forms and methods of using same.
IL143375A0 (en) Sustained release matrix systems for highly soluble drugs
AR006598A1 (es) "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
PL360972A1 (pl) Nowa kompozycja farmaceutyczna w postaci kapsułekcelulozowych odpowiednich dla pochodnych benzimidazolu
AP2003002763A0 (en) Controlled release formulations for oral administration
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
LTIP1722A (en) Therapeutically active substituted benzimidazole and process for its preparation
GR1004193B (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
TW200517127A (en) Novel composition
NZ515349A (en) Polymorphs of a crystalline azabicyclo (2,2,2) octan-3- amine citrate and their pharmaceutical compositions
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
GB9420748D0 (en) 1,5 benzodiazepine derivatives
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje
MY145885A (en) Controlled release formulations for oral administration
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
NO964775L (no) Fast farmasöytisk adenosinholdig preparat

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)